International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
Conferences Published ↓
DePaul-2026
IC-AIRCM-T3-2026
NSSFIGTMA-2025
SPHERE-2025
AIMAR-2025
SVGASCA-2025
ICRTET-4
ICCE-2025
Chinai-2023
PIPRDA-2023
ICMRS'23
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 8 Issue 5
September-October 2026
Indexing Partners
A Distinct Serum Metabolic Profile Characterizes Osteosarcopenia: Identifying Potential Metabolic Biomarkers
| Author(s) | Ms. Nandini Tiwari, Ms. Garima Singh, Mr. Javed Siddiqui, Ms. Rajni Yadav, Ms. Sakshi Kumari |
|---|---|
| Country | India |
| Abstract | Background: Osteosarcopenia, the concurrent presence of osteoporosis and sarcopenia, is associated with elevated fracture risk, frailty, and mortality. Early molecular characterization may enable timely intervention. This study aimed to define a distinct serum metabolic signature of osteosarcopenia and identify candidate biomarkers. Methods: A cross-sectional study enrolled 340 community-dwelling adults aged ≥60 years, classified into four groups: robust (n=120), osteoporosis alone (n=85), sarcopenia alone (n=72), and osteosarcopenia (n=63). Untargeted and targeted serum metabolomics (LC-MS/MS) quantified amino acids, lipids, acylcarnitines, and related metabolites. Clinical assessments included dual-energy X-ray absorptiometry (DXA), handgrip strength, gait speed, and skeletal muscle index (SMI). Multivariate analyses and ROC curves evaluated discriminatory performance. Results: Osteosarcopenia exhibited a unique metabolic profile characterized by reduced branched-chain amino acids (leucine ↓32%, isoleucine ↓29%, valine ↓26%), lower creatinine, elevated citrulline, and altered phospholipid species (notably elevated PI 32:1 and reduced PC species). Pathway enrichment highlighted BCAA metabolism, lipid remodeling, and steroid biosynthesis. Key individual biomarkers showed AUCs of 0.71–0.82; a combined five-metabolite panel achieved AUC 0.91 (95% CI 0.86–0.95) for distinguishing osteosarcopenia from robust controls. Metabolite levels correlated significantly with SMI and bone mineral density. Conclusion: Osteosarcopenia is characterized by a distinct serum metabolic fingerprint involving amino acid catabolism, lipid dysregulation, and inflammatory shifts. Creatinine, leucine, PI 32:1, and a multi-metabolite panel emerge as promising biomarkers for early detection and phenotyping of this high-risk geriatric syndrome. |
| Keywords | Osteosarcopenia; Metabolomics; Biomarkers; Branched-chain amino acids; Phospholipids; Sarcopenia; Osteoporosis; Aging |
| Field | Medical / Pharmacy |
| Published In | Volume 8, Issue 5, September-October 2026 |
| Published On | 2026-09-04 |
| DOI | https://doi.org/10.36948/ijfmr.2026.v08i05.87051 |
Share this

E-ISSN 2582-2160
CrossRef DOI prefix of IJFMR is 10.36948/ijfmr
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
Powered by Sky Research Publication and Journals